IMR Press / FBS / Volume 2 / Issue 2 / DOI: 10.2741/S86

Frontiers in Bioscience-Scholar (FBS) is published by IMR Press from Volume 13 Issue 1 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Clinical biomarkers in hepatocellular carcinoma (HCC)
Show Less
1 Surgical Sciences, Organ Transplantations and New Technologies Department, General and Week Surgery OU University Hospital of Catania, Via S Sofia No 78, 95125 Catania, Italy

*Author to whom correspondence should be addressed.

Academic Editor: Giovanni Li Volti

Front. Biosci. (Schol Ed) 2010, 2(2), 571–577;
Published: 1 January 2010
(This article belongs to the Special Issue Biochemical markers in biological fluids)

The Authors make a review of the most important molecules used today for detecting and screening hepatocellular carcinoma, analyzing their known biological features, advantages and limits especially concerning differential diagnosis from cirrhosis and others diseases. AFP, AFP-L3, DCP, Alpha-1-fucosidase are analyzed and all the current knowledge reviewed, as well as focusing on possible future applications and results of combined determination (what about another word here: evaluation etc) in HCC. Additionally other more recent molecules showing promising future clinical application are cited.

Back to top